Inventor
WU WENGEN
US24 patents
⚠️ This page may combine multiple inventors who share the name “WU WENGEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TUFTS COLLEGE
12 patentsUS11096924B2Aug 24, 2021
Combination therapies using immuno-dash inhibitors and PGE2 antagonists
TUFTS COLLEGE6 citations84
US8933056B2Jan 13, 2015
Soft protease inhibitors and pro-soft forms thereof
TUFTS COLLEGE5 citations84
US10245248B2Apr 2, 2019
FAP-activated therapeutic agents, and uses related thereto
TUFTS COLLEGE5 citations83
US10117887B2Nov 6, 2018
FAP-activated therapeutic agents, and uses related thereto
TUFTS COLLEGE6 citations83
US9737556B2Aug 22, 2017
FAP-activated therapeutic agents, and uses related thereto
TUFTS COLLEGE8 citations83
US11957657B2Apr 16, 2024
Combination therapies using immuno-dash inhibitors and PGE2 antagonists
TUFTS COLLEGE2 citations73
US11583516B2Feb 21, 2023
Dash inhibitors, and uses related thereto
TUFTS COLLEGE3 citations73
US11559537B2Jan 24, 2023
Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists
TUFTS COLLEGE2 citations73
US12478609B2Nov 25, 2025
Combination therapies using immuno-DASH inhibitors and PGE2 antagonists
TUFTS COLLEGE0 citations62
US11707539B2Jul 25, 2023
FAP-targeted radiopharmaceuticals and imaging agents, and uses related thereto
TUFTS COLLEGE0 citations62
US9212142B2Dec 15, 2015
Niacin mimetics, and methods of use thereof
TUFTS COLLEGE2 citations60
US9192646B2Nov 24, 2015
Soft protease inhibitors and pro-soft forms thereof
TUFTS COLLEGE0 citations52
BACH BIOSCIENCES LLC
7 patentsUS11266669B2Mar 8, 2022
FAP-activated therapeutic agents, and uses related thereto
BACH BIOSCIENCES LLC4 citations82
US10709722B2Jul 14, 2020
FAP-activated therapeutic agents, and uses related thereto
BACH BIOSCIENCES LLC5 citations82
US11033525B2Jun 15, 2021
Fap-activated therapeutic agents, and uses related thereto
BACH BIOSCIENCES LLC1 citations71
US12121505B2Oct 22, 2024
Fap-activated therapeutic agents, and uses related thereto
BACH BIOSCIENCES LLC0 citations61
US12053450B2Aug 6, 2024
FAP-activated therapeutic agents, and uses related thereto
BACH BIOSCIENCES LLC0 citations61
US12023316B2Jul 2, 2024
FAP-activated therapeutic agents, and uses related thereto
BACH BIOSCIENCES LLC0 citations61
US11925655B2Mar 12, 2024
FAP-activated therapeutic agents, and uses related thereto
BACH BIOSCIENCES LLC0 citations61
BACHOVCHIN WILLIAM W
5 patentsUS8268880B2Sep 18, 2012
Soft protease inhibitors and pro-soft forms thereof
BACHOVCHIN WILLIAM W9 citations84
US8937063B2Jan 20, 2015
Niacin mimetics, and methods of use thereof
BACHOVCHIN WILLIAM W3 citations59
US8450316B2May 28, 2013
Niacin mimetics, and methods of use thereof
BACHOVCHIN WILLIAM W2 citations57
US8563533B2Oct 22, 2013
Soft protease inhibitors and pro-soft forms thereof
BACHOVCHIN WILLIAM W0 citations52
US8513187B2Aug 20, 2013
Soft protease inhibitors, and pro-soft forms thereof
BACHOVCHIN WILLIAM W0 citations52